Literature DB >> 33395381

Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.

Liselotte van Asten, Carel N Harmsen, Lenny Stoeldraijer, Don Klinkenberg, Anne C Teirlinck, Marit M A de Lange, Adam Meijer, Jan van de Kassteele, Arianne B van Gageldonk-Lafeber, Susan van den Hof, Wim van der Hoek.   

Abstract

Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previous influenza epidemics. Excess deaths per influenza epidemic averaged 4,000. The estimated 9,554 excess deaths (41% in excess) during the COVID-19 epidemic weeks 12-19 of 2020 appeared comparable to the 9,373 excess deaths (18%) during the severe influenza epidemic of 2017-18. However, these deaths occurred in a shorter time, had a higher peak, and were mitigated by nonpharmaceutical control measures. Excess deaths were 1.8-fold higher than reported laboratory-confirmed COVID-19 deaths (5,449). Based on excess deaths and preliminary results from seroepidemiologic studies, we estimated the infection-fatality rate to be 1%. Monitoring of excess deaths is crucial for timely estimates of disease burden for influenza and COVID-19. Our data complement laboratory-confirmed COVID-19 death reports and enable comparisons between epidemics.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; coronavirus disease; epidemics; excess deaths; infection-fatality rate; influenza; influenza viruses; mortality; mortality rate; respiratory infections; seasonality; severe acute respiratory syndrome coronavirus 2; surveillance; the Netherlands; time series; trends; viruses; zoonoses

Mesh:

Year:  2021        PMID: 33395381      PMCID: PMC7853586          DOI: 10.3201/eid2702.202999

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  19 in total

1.  Methods for current statistical analysis of excess pneumonia-influenza deaths.

Authors:  Robert E Serfling
Journal:  Public Health Rep       Date:  1963-06       Impact factor: 2.792

2.  Excess mortality among the elderly in European countries, December 2014 to February 2015.

Authors:  K Molbak; L Espenhain; J Nielsen; K Tersago; N Bossuyt; G Denissov; A Baburin; M Virtanen; A Fouillet; T Sideroglou; K Gkolfinopoulou; A Paldy; J Bobvos; L van Asten; M de Lange; B Nunes; S da Silva; A Larrauri; I L Gomez; A Tsoumanis; C Junker; H Green; R Pebody; J McMenamin; A Reynolds; A Mazick
Journal:  Euro Surveill       Date:  2015-03-19

3.  Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-15       Impact factor: 17.586

4.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

5.  The effect of large-scale anti-contagion policies on the COVID-19 pandemic.

Authors:  Solomon Hsiang; Daniel Allen; Sébastien Annan-Phan; Kendon Bell; Ian Bolliger; Trinetta Chong; Hannah Druckenmiller; Luna Yue Huang; Andrew Hultgren; Emma Krasovich; Peiley Lau; Jaecheol Lee; Esther Rolf; Jeanette Tseng; Tiffany Wu
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

6.  Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method.

Authors:  Tomás Vega; Jose Eugenio Lozano; Tamara Meerhoff; René Snacken; Joshua Mott; Raul Ortiz de Lejarazu; Baltazar Nunes
Journal:  Influenza Other Respir Viruses       Date:  2012-08-16       Impact factor: 4.380

7.  Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study.

Authors:  Benjamin J Cowling; Sheikh Taslim Ali; Tiffany W Y Ng; Tim K Tsang; Julian C M Li; Min Whui Fong; Qiuyan Liao; Mike Yw Kwan; So Lun Lee; Susan S Chiu; Joseph T Wu; Peng Wu; Gabriel M Leung
Journal:  Lancet Public Health       Date:  2020-04-17

8.  Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.

Authors:  Paola Michelozzi; Francesca de'Donato; Matteo Scortichini; Manuela De Sario; Fiammetta Noccioli; Pasqualino Rossi; Marina Davoli
Journal:  Euro Surveill       Date:  2020-05

9.  European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

Authors:  J Nielsen; L S Vestergaard; L Richter; D Schmid; N Bustos; T Asikainen; R Trebbien; G Denissov; K Innos; M J Virtanen; A Fouillet; T Lytras; K Gkolfinopoulou; M An der Heiden; L Grabenhenrich; H Uphoff; A Paldy; J Bobvos; L Domegan; J O'Donnell; M Scortichini; A de Martino; J Mossong; K England; J Melillo; L van Asten; M Ma de Lange; R Tønnessen; R A White; S P da Silva; A P Rodrigues; A Larrauri; C Mazagatos; A Farah; A D Carnahan; C Junker; M Sinnathamby; R G Pebody; N Andrews; A Reynolds; J McMenamin; C S Brown; C Adlhoch; P Penttinen; K Mølbak; T G Krause
Journal:  Clin Microbiol Infect       Date:  2019-02-18       Impact factor: 8.067

10.  Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011.

Authors:  J Nielsen; A Mazick; N Andrews; M Detsis; T M Fenech; V M Flores; A Foulliet; B Gergonne; H K Green; C Junker; B Nunes; J O'Donnell; A Oza; A Paldy; R Pebody; A Reynolds; T Sideroglou; B E Snijders; F Simon-Soria; H Uphoff; L VAN Asten; M J Virtanen; F Wuillaume; K Mølbak
Journal:  Epidemiol Infect       Date:  2012-11-27       Impact factor: 4.434

View more
  6 in total

1.  Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome.

Authors:  Diego Real de Asua; Miguel A Mayer; María Del Carmen Ortega; Jose M Borrel; Teresa de Jesús Bermejo; Domingo González-Lamuño; Coral Manso; Fernando Moldenhauer; María Carmona-Iragui; Anke Hüls; Stephanie L Sherman; Andre Strydom; Rafael de la Torre; Mara Dierssen
Journal:  J Clin Med       Date:  2021-08-23       Impact factor: 4.241

2.  The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan.

Authors:  Shinya Tsuzuki; Norio Ohmagari; Philippe Beutels
Journal:  Epidemiol Infect       Date:  2021-12-10       Impact factor: 4.434

3.  Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.

Authors:  Sarah K Nørgaard; Lasse S Vestergaard; Jens Nielsen; Lukas Richter; Daniela Schmid; Natalia Bustos; Toon Braye; Maria Athanasiadou; Theodore Lytras; Gleb Denissov; Tatjana Veideman; Oskari Luomala; Teemu Möttönen; Anne Fouillet; Céline Caserio-Schönemann; Matthias An der Heiden; Helmut Uphoff; Kassiani Gkolfinopoulou; Janos Bobvos; Anna Paldy; Naama Rotem; Irene Kornilenko; Lisa Domegan; Joan O'Donnell; Francesca De Donato; Matteo Scortichini; Patrick Hoffmann; Telma Velez; Kathleen England; Neville Calleja; Liselotte van Asten; Lenny Stoeldraijer; Richard A White; Trine H Paulsen; Susana P da Silva; Ana P Rodrigues; Petra Klepac; Metka Zaletel; Mario Fafangel; Amparo Larrauri; Inmaculada León; Ahmed Farah; Ilias Galanis; Christoph Junker; Damir Perisa; Mary Sinnathamby; Nick Andrews; Mark G O'Doherty; David Irwin; Sharon Kennedy; Jim McMenamin; Cornelia Adlhoch; Nick Bundle; Pasi Penttinen; Jukka Pukkila; Richard Pebody; Tyra G Krause; Kåre Mølbak
Journal:  Euro Surveill       Date:  2021-01

4.  Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design.

Authors:  Daisuke Onozuka; Yuta Tanoue; Shuhei Nomura; Takayuki Kawashima; Daisuke Yoneoka; Akifumi Eguchi; Chris Fook Sheng Ng; Kentaro Matsuura; Shoi Shi; Koji Makiyama; Shinya Uryu; Yumi Kawamura; Shinichi Takayanagi; Stuart Gilmour; Takehiko I Hayashi; Hiroaki Miyata; Francesco Sera; Tomimasa Sunagawa; Takuri Takahashi; Yuuki Tsuchihashi; Yusuke Kobayashi; Yuzo Arima; Kazuhiko Kanou; Motoi Suzuki; Masahiro Hashizume
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

5.  Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020-April 2021.

Authors:  Wha-Eum Lee; Sang Woo Park; Daniel M Weinberger; Donald Olson; Lone Simonsen; Bryan T Grenfell; Cécile Viboud
Journal:  medRxiv       Date:  2022-02-15

6.  Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients.

Authors:  Shinya Tsuzuki; Yusuke Miyazato; Mari Terada; Shinichiro Morioka; Norio Ohmagari; Philippe Beutels
Journal:  Health Qual Life Outcomes       Date:  2022-08-19       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.